|
C9ORF30 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.398200E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.930000E-02 |
| Normal-vs-Stage2 |
1.127810E-02 |
| Normal-vs-Stage3 |
1.957790E-03 |
| Normal-vs-Stage4 |
1.495370E-03 |
| Stage1-vs-Stage2 |
1.437580E-01 |
| Stage1-vs-Stage3 |
1.428070E-02 |
| Stage1-vs-Stage4 |
2.703900E-02 |
| Stage2-vs-Stage3 |
2.083600E-01 |
| Stage2-vs-Stage4 |
3.587000E-01 |
| Stage3-vs-Stage4 |
8.206000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.623700E-03 |
| Normal-vs-AfricanAmerican |
8.504900E-03 |
| Normal-vs-Asian |
4.574400E-01 |
| Caucasian-vs-AfricanAmerican |
5.917600E-01 |
| Caucasian-vs-Asian |
8.938800E-01 |
| AfricanAmerican-vs-Asian |
9.595600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.002580E-01 |
| Normal-vs-Female |
6.16669999509156E-08 |
| Male-vs-Female |
1.78429999664331E-08 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.292160E-02 |
| Normal-vs-Extreme_Weight |
7.979900E-02 |
| Normal-vs-Obese |
2.841700E-03 |
| Normal-vs-Extreme_Obese |
1.692230E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.540400E-01 |
| Normal_Weight-vs-Obese |
4.699400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.328400E-01 |
| Extreme_Weight-vs-Obese |
7.167800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.719400E-01 |
| Obese-vs-Extreme_Obese |
5.285800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.632320E-02 |
| Normal-vs-Age(41-60Yrs) |
1.953580E-04 |
| Normal-vs-Age(61-80Yrs) |
1.037770E-01 |
| Normal-vs-Age(81-100Yrs) |
3.189200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.214200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.558400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.419900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.520000E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.559900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.387000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.947600E-01 |
| Normal-VS-Type2 PRCC |
1.800630E-03 |
| Normal-VS-KIRP CIMP |
1.018090E-04 |
| Normal-VS-Unclassified PRCC |
5.759700E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.359780E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.16879839140438E-11 |
| Type1 PRCC-VS-Unclassified PRCC |
2.601900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.405200E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
7.272000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.05489999999253E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.460300E-02 |
| Normal-vs-N1 |
7.360400E-04 |
| Normal-vs-N2 |
7.63089999999966E-05 |
| N0-vs-N1 |
1.283400E-01 |
| N0-vs-N2 |
1.882840E-01 |
| N1-vs-N2 |
5.071600E-01 |
|
|
